Projekt
SOS AMI Selatogrel
Laufend - Rekrutierung – laufend · 2022 bis 2026
Maeder Micha, Vetsch Susanne, Fink Karin
Art
Reichweite
Bereiche
Status
Start
Ende
Finanzierungsart
Studiendesign
Kurzbeschreibung/Zielsetzung
Multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of self-administered subcutaneous selatogrel for prevention of all-cause death and treatment of acute myocardial infarction in subjects with a recent history of acute myocardial infarction